909 related articles for article (PubMed ID: 18087189)
1. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
[TBL] [Abstract][Full Text] [Related]
2. PIVKA-II is the best prognostic predictor in patients with hepatocellular carcinoma after radiofrequency ablation therapy.
Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Nagai T; Minami Y; Ueshima K
Oncology; 2008; 75 Suppl 1():91-8. PubMed ID: 19092277
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation.
Takahashi S; Kudo M; Chung H; Inoue T; Nagashima M; Kitai S; Tatsumi C; Minami Y; Ueshima K; Fukunaga T; Haji S
Dig Dis; 2007; 25(4):303-9. PubMed ID: 17960064
[TBL] [Abstract][Full Text] [Related]
4. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.
Kobayashi M; Ikeda K; Kawamura Y; Yatsuji H; Hosaka T; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H
Cancer; 2009 Feb; 115(3):571-80. PubMed ID: 19117347
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients.
Hiraoka A; Michitaka K; Horiike N; Hidaka S; Uehara T; Ichikawa S; Hasebe A; Miyamoto Y; Ninomiya T; Sogabe I; Ishimaru Y; Kawasaki H; Koizumi Y; Hirooka M; Yamashita Y; Abe M; Hiasa Y; Matsuura B; Onji M
J Gastroenterol Hepatol; 2010 Feb; 25(2):403-7. PubMed ID: 19929922
[TBL] [Abstract][Full Text] [Related]
6. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
7. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
8. Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study.
Kudo M; Sakaguchi Y; Chung H; Hatanaka K; Hagiwara S; Ishikawa E; Takahashi S; Kitai S; Inoue T; Minami Y; Ueshima K
Oncology; 2007; 72 Suppl 1():132-8. PubMed ID: 18087194
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
Peng ZW; Zhang YJ; Chen MS; Liang HH; Li JQ; Zhang YQ; Lau WY
Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
11. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
12. [The factors related to the prognosis of solitary hepatocellular carcinoma after radiofrequency ablation].
Chung IK; Park MJ; Kwon KT; Park YD; Chung YJ; Jeon SW; Lee MK; Seo HE; Lee YD; Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH
Korean J Hepatol; 2005 Dec; 11(4):371-80. PubMed ID: 16380666
[TBL] [Abstract][Full Text] [Related]
13. Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response.
Guglielmi A; Ruzzenente A; Pachera S; Valdegamberi A; Sandri M; D'Onofrio M; Iacono C
Am J Gastroenterol; 2008 Mar; 103(3):597-604. PubMed ID: 17970836
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results.
Peng ZW; Zhang YJ; Chen MS; Lin XJ; Liang HH; Shi M
Eur J Surg Oncol; 2010 Nov; 36(11):1054-60. PubMed ID: 20846819
[TBL] [Abstract][Full Text] [Related]
16. [Survival and prognostic analysis of radiofrequency ablation of hepatocellular carcinoma].
Yang W; Chen MH; Gao W; Wu W; Huo L; Dai WD; Liu WY; Yan K
Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):169-73. PubMed ID: 16635345
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
Komorizono Y; Oketani M; Sako K; Yamasaki N; Shibatou T; Maeda M; Kohara K; Shigenobu S; Ishibashi K; Arima T
Cancer; 2003 Mar; 97(5):1253-62. PubMed ID: 12599233
[TBL] [Abstract][Full Text] [Related]
18. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
Xia JL; Ye SL; Zou JH; Ren ZG; Gan YH; Wang YH; Chen Y; Ge NL; Tang ZY; Yang BH
Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186
[TBL] [Abstract][Full Text] [Related]
19. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation.
Ito T; Takada Y; Ueda M; Haga H; Maetani Y; Oike F; Ogawa K; Sakamoto S; Ogura Y; Egawa H; Tanaka K; Uemoto S
Liver Transpl; 2007 Dec; 13(12):1637-44. PubMed ID: 18044766
[TBL] [Abstract][Full Text] [Related]
20. Factors in successful radiofrequency ablation therapy for malignant liver tumors.
Sakakima Y; Inoue S; Takeda S; Kaneko T; Nakao A
Hepatogastroenterology; 2004; 51(60):1761-5. PubMed ID: 15532821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
